...
首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions
【24h】

Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions

机译:羟考酮/纳洛酮的药代动力学及其在血液透析期间末期肾病患者中的代谢产物

获取原文
获取原文并翻译 | 示例
           

摘要

Background The pharmacokinetics of oxycodone in patients with end-stage renal disease (ESRD) requiring haemodialysis are largely unknown. Therefore, we investigated the pharmacokinetics of oxycodone/naloxone prolonged release and their metabolites in patients with ESRD during and between haemodialysis sessions.
机译:背景技术需要血液透析患者催产酮的羟考酮(ESRD)的药代动力学主要是未知的。 因此,我们调查了羟考酮/纳洛酮的药代动力学延长释放及其在血液透析期间和血液透析次数之间的患者中的代谢物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号